Alcohol & longevity: what current research shows about regular consumption
For decades, a glass of red wine in the evening was considered good for the heart. Newer studies challenge this myth. What current research really knows about alcohol and health — and why the question is more complex than it seems.
The myth of the protective wine
For decades, cardiologists cited studies showing that moderate alcohol drinkers had lower cardiovascular mortality than abstainers. The best-known explanation was resveratrol in red wine. The problem: resveratrol occurs in amounts far below pharmacologically effective doses. And the studies suffered from a systematic bias.
Many abstainers in older cohort studies were former drinkers who had stopped due to health problems. When this group is used as the reference, moderate drinkers automatically look healthier — not because alcohol protects, but because the control group was sicker. This so-called sick quitter bias skewed results for years.
What newer studies show
Mendelian randomization studies get around the bias problem: they use genetic variants associated with lower alcohol consumption to estimate the causal effect of alcohol. Several such studies — including a large analysis in PLOS Medicine by Holmes et al. — found no positive cardiovascular effect from moderate consumption. Instead, even low consumption was associated with a slightly increased risk for certain cancers, particularly breast cancer and colorectal cancer.
An analysis of the Global Burden of Disease study using data from 195 countries concluded in The Lancet in 2018 that the safe level of alcohol is zero — which made headlines, but is an oversimplification. Cancer risks rose even at very small amounts, but the absolute numbers for an occasional drinker are very different from those for a heavy drinker.
Sleep, recovery and heart rate variability
Even moderate amounts of alcohol demonstrably affect sleep architecture. Alcohol promotes falling asleep, but suppresses REM sleep and increases wake periods in the second half of the night when the alcohol is metabolised. This is shown both by polysomnography studies and data from large wearable studies.
Heart rate variability — a marker of recovery quality — drops measurably when alcohol is consumed. Users of Whoop, Oura and similar trackers consistently report that even a single glass of wine in the evening lowers their recovery score the next morning.
An honest assessment
Alcohol is a legal recreational substance with cultural significance — and a substance that causes biological costs with regular consumption. These costs are well documented at high consumption: liver disease, increased cancer risk, brain changes. At very low consumption — one to two drinks per week — the absolute risks are small, but not zero.
What current research does not clearly show: whether moderate consumption of one to seven units per week is net harmful or neutral. That depends on the pattern — daily drinking versus occasional drinking — and on individual factors such as genetics and overall lifestyle.
Alcohol and the YUTHI app
If you want to know how alcohol affects you personally, you can track your consumption and sleep quality in parallel in the YUTHI app. The app shows you over weeks and months whether a pattern is emerging.
You can additionally track biomarkers such as GGT or liver enzymes, which can be measured by a doctor. Not because they would be relevant after an occasional glass of wine — but because they give you a picture of how your liver responds to your consumption patterns.
That was the snapshot. The app turns it into daily support.
Measure every day instead of calculating once: Vito or Vita puts your numbers in context, builds you a weekly plan and speaks up when something stands out.
Launching at the end of 2026 — iPhone first, Android to follow. Let me know when it’s out ↓
Sources
- Holmes MV et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ, 349:g4164, 2014.
- GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016. The Lancet, 392(10152):1015–1035, 2018.
- Ebrahim S et al. Alcohol and income; social disadvantage and the benefits of mendelian randomisation. Alcohol and Alcoholism, 50(3):244–250, 2015.
